Abstract
This study presents a comprehensive analysis of the impact of the anti-reversion agent, 3-(bis citraconimidomethyl) Benzene, Perkalink 900, on the properties, with a focus on reversion tendencies, of carbon black-filled ethylene-propylene-diene monomer (EPDM) rubber compounds cured using a semi-efficient vulcanization (SEV) sulfur curing system with various accelerators. The research highlights that the presence of Perkalink 900 significantly prolongs the optimum cure times for all rubber compounds, reducing ∆torques, especially in fast-curing systems. Crosslink density (CLD) exhibits minimal sensitivity to Perkalink 900, which effectively prevents reversion, even reaching zero in certain compounds. Reversion extent varies with the chosen curing system, and the concentration of Perkalink 900 plays a key role in its control. Perkalink 900 enhances Shore A hardness, indicating a denser and stiffer rubber, while tear strength and elongation at break improve. Tensile strength remains stable or slightly increases, and the modulus response varies based on the curing agent and Perkalink 900 loading. ATR-FTIR spectra confirm Perkalink 900 presence, with peak intensities correlating with its concentration. Additionally, a new Alder-ene reaction mechanism between EPDM and Perkalink 900 is proposed. Overall, the study establishes Perkalink 900 as an effective anti-reversion agent, proving its potential to significantly enhance rubber compound properties. Future investigations could focus on optimizing Perkalink 900 concentrations for specific applications and exploring its interactions with diverse rubber types and curing systems.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
More From: Progress in Rubber, Plastics and Recycling Technology
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.